| Literature DB >> 35356548 |
Tommy Pan1, Matthew J Bierowski1, Tonya S King2, Mark W Mason3.
Abstract
Background: In the United States, the number of revision total hip arthroplasty (THA) cases is projected to grow from 50,000 in 2014 to 85,000 by 2030. The anterior-based muscle sparing approach (ABMS) has been described as a viable approach for primary THA, but little has been written in the revision setting. This study compares the supine ABMS approach to alternative approaches in revision THA. Material and methods: A retrospective review was performed on 149 revision THAs from 2016 to 2019. The ABMS, modified Müller Hardinge (MMH), and posterolateral (PL) approaches were studied. Age, reason for arthroplasty, length of operation, length of stay, blood loss, and complications were extracted. Clinical outcomes were measured by the Hip Disability and Osteoarthritis Outcome Score, Modified Harris Hip Score, University of California Los Angeles activity score, and Veterans RAND 12 Mental/Physical scores.Entities:
Keywords: Anterior based muscle-sparing approach; Extensile approach; Outcomes; Revision hip arthroplasty
Year: 2022 PMID: 35356548 PMCID: PMC8958257 DOI: 10.1016/j.artd.2022.02.016
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Baseline characteristics and demographics.
| Characteristic | ABMS | MMH | PL | |
|---|---|---|---|---|
| Age | 61.2 | 67.9 | 68.1 | .028 |
| BMI | 30.7 | 31.6 | 29.1 | .17 |
| Gender (male) | 22 (42.3%) | 26 (44.8%) | 18 (46.2%) | .93 |
| Smoking | 28 (53.9%) | 23 (39.7%) | 18 (46.2%) | .33 |
| Diabetes | 11 (21.2%) | 14 (24.1%) | 5 (12.8%) | .39 |
| Hypertension | 35 (67.3%) | 35 (60.3%) | 25 (64.1%) | .75 |
| CKD | 0 (0.0%) | 1 (1.7%) | 1 (2.6%) | .55 |
| Immunosuppression | 5 (9.6%) | 10 (17.2%) | 4 (10.3%) | .42 |
| Blood thinners | 11 (21.2%) | 39 (67.2%) | 11 (28.2%) | <.001 |
| Extensile approach | 12 (23.1%) | 26 (44.8%) | 13 (33.3%) | .056 |
| Explant infection | 5 (9.6%) | 5 (8.6%) | 9 (23.1%) | .08 |
| Head & liner exchange | 8 (15.4%) | 20 (34.5%) | 8 (20.5%) | .054 |
| Acetabular exchange | 19 (36.5%) | 11 (19.0%) | 10 (25.6%) | .11 |
| Femur exchange | 10 (19.2%) | 13 (22.4%) | 2 (5.1%) | .07 |
| All-component exchange | 10 (19.2%) | 9 (15.5%) | 10 (25.6%) | .47 |
CKD, chronic kidney disease.
Indications for revision arthroplasty.
| Indication | ABMS | MMH | PL | Total, % |
|---|---|---|---|---|
| Adverse local tissue reaction | 3 | 10 | 2 | 15, 10.1 |
| Aseptic loosening | 14 | 13 | 4 | 31, 20.8 |
| Bearing surface wear (poly wear) | 3 | 5 | 0 | 8, 5.4 |
| Failed hemiarthroplasty | 3 | 1 | 1 | 5, 3.4 |
| Infection, explant | 4 | 13 | 11 | 28, 18.8 |
| Instability | 10 | 6 | 10 | 26, 17.4 |
| Pelvic discontinuity | 1 | 0 | 2 | 3, 2.0 |
| PPF | 7 | 5 | 4 | 16, 10.7 |
| Infection, reimplant | 7 | 5 | 5 | 17, 11.4 |
PPF, periprosthetic fracture.
Component exchange type and complex revision subtypes by THA approach.
| Exchange type | ABMS | MMH | PL | Total, % |
|---|---|---|---|---|
| Explant for infection | 5 | 5 | 9 | 19, 12.7 |
| Head & polyethylene liner exchange | 8 | 20 | 8 | 36, 24.2 |
| Acetabular exchange | 19 | 11 | 10 | 40, 26.8 |
| Femoral exchange | 10 | 13 | 2 | 25, 16.8 |
| All-component exchange | 10 | 9 | 10 | 29, 19.5 |
| Complex subtype | ABMS | MMH | PL | Total |
| Acetabular augments | 0 | 0 | 4 | 4 |
| Acetabular cages | 3 | 4 | 1 | 8 |
| Extended trochanteric osteotomy | 4 | 10 | 7 | 21 |
| Hardware removal | 1 | 4 | 1 | 6 |
| PPF: acetabulum | 1 | 0 | 0 | 1 |
| PPF: femur | 5 | 7 | 3 | 15 |
| Extensile approach | 12 | 21 | 11 | 44 |
PPF, periprosthetic fracture.
Perioperative findings by surgeon.
| Surgeon | Cases | THA approach(es) | Experience (y) | LOO geometric mean (min) | LOS median (d) | EBL geometric mean (mL) | Complications |
|---|---|---|---|---|---|---|---|
| 1 | 57 | 55 MMH, 2 PL | >15 | 171.7 | 1.0 | 445.0 | 9 (15.8%) |
| 2 | 9 | 9 PL | >15 | 160.1 | 1.0 | 271.3 | 1 (11.1%) |
| 3 | 14 | 14 PL | 0-5 | 180.4 | 3.0 | 360.9 | 2 (14.3%) |
| 4 | 58 | 52 ABMS, 3 MMH, 3 PL | >15 | 144.8 | 1.0 | 397.6 | 7 (12.1%) |
| 5 | 11 | 11 PL | 0-5 | 206.8 | 2.0 | 513.6 | 1 (9.1%) |
Complication types by revision THA approach.
| Complication | ABMS | MMH | PL | Total |
|---|---|---|---|---|
| Dislocation | 0/52 | 1/58 | 0/39 | 1/21 |
| Prosthetic joint infection | 3/52 | 4/58 | 3/39 | 10/21 |
| Iatrogenic nerve palsy | 4/21 | |||
| Femoral | 1/52 | 0/58 | 0/39 | |
| Peroneal | 0/52 | 0/58 | 1/39 | |
| Sciatic | 1/52 | 1/58 | 0/39 | |
| Periprosthetic fracture | 1/52 | 3/58 | 1/39 | 5/21 |
| Pulmonary embolism | 0/52 | 0/58 | 1/39 | 1/21 |
Mean-adjusted change in outcome score (preop vs 1-year postop).
| Outcome score | Model-adjusted mean | 95% Confidence intervals | ||
|---|---|---|---|---|
| HOOS | .55 | |||
| ABMS | 13.6 | −8.7 | 35.8 | |
| MMH | 17.4 | 4.8 | 29.9 | |
| PL | 30.2 | 6.9 | 53.4 | |
| UCLA activity score | .30 | |||
| ABMS | 0.26 | −1.18 | 1.70 | |
| MMH | 1.12 | 0.340955 | 1.93 | |
| PL | 1.88 | 0.406003 | 3.38 | |
| HSS | .72 | |||
| ABMS | 21.2 | 0.52 | 41.9 | |
| MMH | 13.7 | 0.07 | 27.4 | |
| PL | 23.2 | −2.12 | 48.5 | |
| VR mental | .67 | |||
| ABMS | −4.56 | −16.7 | 7.6 | |
| MMH | 1.07 | −6.2 | 8.3 | |
| PL | −2.11 | −14.5 | 10.3 | |
| VR physical | .12 | |||
| ABMS | 7.2 | −3.8 | 18.2 | |
| MMH | 3.7 | −2.8 | 10.2 | |
| POST | 17.6 | 6.4 | 28.7 | |
HOOS, Hip Disability Osteoarthritis Outcome Scores; VR, Veterans RAND; HSS, Hospital for Special Surgery; UCLA, University of California, Los Angeles; ABMS, anterior based muscle sparing approach; MMH, modified Meuller-Hardinge approach; POST, posterolateral approach.